Switch to: References

Add citations

You must login to add citations.
  1. “Author TBD”: Radical Collaboration in Contemporary Biomedical Research.Rebecca Kukla - 2012 - Philosophy of Science 79 (5):845-858.
    Ghostwriting scandals are pervasive in industry-funded biomedical research, and most responses to them have presumed that they represent a sharp transgression of the norms of scientific authorship. I argue that in fact, ghostwriting represents a continuous extension of current socially accepted authorship practices. I claim that the radically collaborative, decentralized, interdisciplinary research that forms the gold standard in medicine is in an important sense unauthored, and that this poses a serious problem in applied social epistemology. It is no easy matter (...)
    Download  
     
    Export citation  
     
    Bookmark   30 citations  
  • Credibility Engineering in the Food Industry: Linking Science, Regulation, and Marketing in a Corporate Context.Bart Penders & Annemiek P. Nelis - 2011 - Science in Context 24 (4):487-515.
    ArgumentWe expand upon the notion of the “credibility cycle” through a study of credibility engineering by the food industry. Research and development (R&D) as well as marketing contribute to the credibility of the food company Unilever and its claims. Innovation encompasses the development, marketing, and sales of products. These are directed towards three distinct audiences: scientific peers, regulators, and consumers. R&D uses scientific articles to create credit for itself amongst peers and regulators. These articles are used to support health claims (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • The Disposable Author: How Pharmaceutical Marketing Is Embraced within Medicine's Scholarly Literature.Alastair Matheson - 2016 - Hastings Center Report 46 (4):31-37.
    The best studies on the relationship between pharmaceutical corporations and medicine have recognized that it is an ambiguous one. Yet most scholarship has pursued a simpler, more saleable narrative in which pharma is a scheming villain and medicine its maidenly victim. In this article, I argue that such crude moral framing blunts understanding of the murky realities of medicine's relationship with pharma and, in consequence, holds back reform. My goal is to put matters right in respect to one critical area (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Intellectual property and global health: from corporate social responsibility to the access to knowledge movement.Cristian Timmermann & Henk van den Belt - 2013 - Liverpool Law Review 34 (1):47-73.
    Any system for the protection of intellectual property rights (IPRs) has three main kinds of distributive effects. It will determine or influence: (a) the types of objects that will be developed and for which IPRs will be sought; (b) the differential access various people will have to these objects; and (c) the distribution of the IPRs themselves among various actors. What this means to the area of pharmaceutical research is that many urgently needed medicines will not be developed at all, (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations